Moreover, to determine the tumor properties of malignant transformed cells, we performed immunohistochemical (IHC) using the lung squamous cell carcinoma (LUSC) marker P63 and the lung adenocarcinoma (LUAD) marker TTF‐1. This evidence concerns the gene TTF1 and squamous cell lung carcinoma.